Name | Value |
---|---|
Revenues | 86.5M |
Cost of Revenue | 77.0M |
Gross Profit | 9.5M |
Operating Expense | 73.8M |
Operating I/L | -96.9M |
Other Income/Expense | 14.4M |
Interest Income | 0.0M |
Pretax | -82.5M |
Income Tax Expense | -1.4M |
Net Income/Loss | -81.1M |
Lannett Company, Inc. is a pharmaceutical company that specializes in developing, manufacturing, packaging, marketing, and distributing generic versions of brand pharmaceutical products in the United States. The company offers a wide range of solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs across various therapeutic areas. Its primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, and other pharmaceuticals. Lannett sells its products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, and other pharmaceutical companies, generating revenue through these distribution channels.